Original Articles: Autoimmunity and Clinical Immunology
Autoimmunity and clinical immunology as a discipline focuses on the understanding and treating a wide range of autoimmune diseases, where the body's immune system mistakenly attacks its tissues. These diseases, including rheumatoid arthritis, systemic lupus, and multiple sclerosis, can affect various organs and systems, leading to chronic inflammation and tissue damage. Clinical immunologists study the complex mechanisms underlying autoimmunity and develop innovative treatment strategies to manage these conditions effectively.
In recent years, there has been a growing understanding of autoimmunity and significant advancements in clinical immunology. Researchers are uncovering new insights into the genetic, environmental, and immunological factors contributing to autoimmune diseases.
Explore our specialized article collection on Autoimmunity and Clinical Immunology!
To add the references below to your reference management program: 1. Download the file; 2. Open your reference management program or EndNote; 3. Select File and import |
80 Articles |
-
Gastrointestinal Barrier Disruption in Post-COVID Syndrome Fatigue Patients
Rohrhofer, J., Wolflehner, V., Schweighardt, J., et al. Allergy. First published:15 May 2025
-
Patient-Reported Outcomes in the Phase III OASIS-HAE Study of Donidalorsen for Hereditary Angioedema
Riedl, M.A., Yarlas, A., Bordone, L., et al. Allergy. First published:19 April 2025
-
Hypereosinophilia and Hypereosinophilic Syndromes: First Findings From a Nationwide Multicenter Cohort
Lefèvre, G., Bleuse, S., Puyade, M., et al.Allergy. First published: 05 January 2025
-
Notch4 regulatory T cells and SARS-CoV-2 viremia shape COVID19 survival outcome
Benamar M, Lai PS, Huang C-Y, et al. Allergy. First published: 03 October 2024
-
Anti-TNF therapy impairs both short- and long-term IgG responses after repeated vaccination
Buhre JS, Pongracz T, Geisen UM, et al. Allergy. First published: 25 July 2024
-
Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after mRNA vaccination
Valk AM, Keijser JBD, van Dam KPJ, et al. Allergy. First published: 04 March 2024
-
T-cell immune profile in blood of systemic mastocytosis: Association with disease features
Pérez-Pons A, Teodosio C, Jara-Acevedo M, et al. Allergy. First published: 01 February 2024
-
A phase 2 open-label extension study of prekallikrein inhibition with donidalorsen for hereditary angioedema
Petersen RS, Bordone L, Riedl MA, et al. Allergy. First published: 27 November 2023
-
Emollients for prevention of atopic dermatitis; 5-year findings from the BEEP randomised trial
Bradshaw, L.E., Wyatt, L.A., Brown, S.J., et al. Allergy. First published: 19 October 2022
-
Delayed type hypersensitivity reactions to various allergens may differently model inflammatory skin diseases
Pavel, A.B., Del Duca, E., Cheng, J., et al. Allergy. First published: 30 September 2022
-
Resensitisation in suspected penicillin allergy
Doña, I., Guidolin, L., Bogas, G., et al. Allergy. First published: 06 September 2022
-
Exposure to avian coronavirus vaccines is associated with increased levels of SARS-CoV-2-cross-reactive antibodies
Ardicli, O, Carli, KT, Satitsuksanoa, P, et al. et al. Allergy. First published: 23 July 2022
-
Personalized diagnostic approach and indirect quantification of extravasation in human anaphylaxis
Nuñez-Borque, E., Betancor, D., Carlos, P.-V., et al. Allergy. First published: 16 July 2022
-
T cell recovery and evidence of persistent immune activation 12 months after severe COVID-19
Taeschler, P., Adamo, S., Deng, Y., et al. Allergy. First published: 14 May 2022
-
Comparing the levels of CTLA-4 dependent biological defects in patients with LRBA deficiency and CTLA-4 insufficiency
Catak, M.C., Akcam, B., Bilgic Eltan, S., et al. Allergy. First published: 01 May 2022
-
Real-life evaluation of molecular multiplex IgE test methods in the diagnosis of pollen associated food allergy
Luisa, D, Bellinda, N, Rohrhofer, J, et al. Allergy. First published: 29 Apr 2022
-
Effect of BTN162b2 and Coronavac boosters on humoral and cellular immunity of individuals previously fully vaccinated with Coronavac against SARS-CoV-2: A longitudinal study
Kuloğlu, Z.E., El, R., Guney-Esken, et al. Allergy. First published: 19 April 2022
-
Methylation risk scores for childhood aeroallergen sensitization: Results from the LISA birth cohort
Kilanowski, A., Chen, J., Everson, T., et al. Allergy. First published: 19 April 2022
-
Development of the cold urticaria activity score
Ahsan, D. M., Altrichter, S., Gutsche, A., et al. Allergy. First published: 11 April 2022
-
Single low-dose exposure to cow’s milk at diagnosis accelerates cow’s milk allergic infants’ progress on a milk ladder programme
d’Art, Y.M., Forristal, L., Byrne, A.M., et al. Allergy. First published: 11 April 2022
-
Autoantibodies in COVID-19 correlate with anti-viral humoral responses and distinct immune signatures
Taeschler, P., Cervia, C., Zurbuchen, Y., et al. Allergy. First published: 01 April 2022
-
Vaccine based on folded RBD-PreS fusion protein with potential to induce sterilizing immunity to SARS-CoV-2 variants
Gattinger, P., Kratzer, B., Tulaeva, I., et al. Allergy. First published: 31 March 2022
-
Humoral immune response of Sinopharm/BBIBP COVID-19 vaccination before and after the booster immunization
Cheng, Z.J., Huang, H., Zheng, P., et al. Allergy. First published: 07 March 2022
-
Interdependencies of cellular and humoral immune responses in heterologous and homologous SARS-CoV-2 vaccination
Hollstein, M.M., Münsterkötter, L., Schön, M.P., et al. Allergy. First published: 06 February 2022
-
Characterization of eosinophilic esophagitis variants by clinical, histological and molecular analyses: A cross-sectional multi-center study
Greuter, T., Straumann, A., Fernandez-Marrero, Y., et al. Allergy. First published: 29 January 2022
-
Longitudinal analyses of development of the immune system during the first five years of life in relation to lifestyle
Olin, A., Acevedo, N., Lakshmikanth, T., et al. Allergy. First published: 29 January 2022
-
Serological testing for SARS-CoV-2 antibodies in clinical practice: a comparative diagnostic accuracy study
Horn, M.P., Jonsdottir, H.R., Brigger, D., et al. Allergy. First published: 05 January 2022
-
Understanding uncontrolled severe allergic asthma by integration of omic and clinical data
Delgado-Dolset, MI, Obeso, D, Rodríguez-Coira, J, et al. Allergy. First published: 28 November 2021
-
Isolation of nanobodies with potential to reduce patients´ IgE binding to Bet v 1 (68/100 characters)
Zettl, I., Ivanova, T., Strobl, M.R., Weichwald, C., et al. Allergy. First published: 27 November 2021
-
Analysis of BNT162b2- and CVnCoV-elicited sera and of convalescent sera toward SARS-CoV-2 viruses
Hein, S, Herrlein, M-L, Mhedhbi, I, et al. Allergy.First published: 25 November 2021
-
Mapping the food allergy quality of life questionnaire parent form onto the Short-Form Six-Dimensions 2
Watts, Y., Dufresne, É., Samaan, K., Graham, F., et al. Allergy. First published: 25 November 2021
-
Measurement of IgE to hazelnut allergen components cannot replace hazelnut challenge in Dutch adults
Lyons, SA, J.Welsing, PM, Hakobyan, M, et al. Allergy. First published: 03 November 2021
-
Development and validation of the food allergy severity score
Fernández-Rivas, M, Gómez García, I, Gonzalo-Fernández, A, et al. Allergy. First published: 30 October 2021
-
Enrichment of infant formula with long-chain polyunsaturated fatty acids and risk of infection and allergy in the nationwide ELFE birth cohort
Adjibade, M., Davisse-Paturet, C., Bernard, J.Y., et al. Allergy. First published: 09 October 2021
-
Large-scale provocation studies identify maladaptive responses to ubiquitous aeroallergens as a correlate of severe allergic rhinoconjunctivitis and asthma
Smith, A.M., Ramirez, R.M., Harper, N., et al. Allergy. First published: 04 October 2021
-
Patients with systemic sclerosis show phenotypic and functional defects in neutrophils
Impellizzieri, D, Egholm, C, Valaperti, A, Distler, O, Boyman, O. Allergy.First published: 01 September 2021
-
Neutralization of SARS-CoV-2 requires antibodies against conformational receptor-binding domain epitopes
Gattinger, P., Niespodziana, K., Stiasny, K., et al. Allergy.First published: 28 August 2021
-
Evolution and long-term outcomes of combined immunodeficiency due to CARMIL2 deficiency
Kolukisa, B., Baser, D., Akcam, B., et al. Allergy.First published: 20 July 2021
-
Antibody response after one and two jabs of the BNT162b2 vaccine in nursing home residents: The CONsort-19 study
Blain, H., Tuaillon, E., Gamon, L., et al. Allergy.First published: 19 July 2021
-
The maternal diet index in pregnancy is associated with offspring allergic diseases: the Healthy Start study
Venter, C, Palumbo, MP, Glueck, DH, et al.Allergy. First published: 22 May 2021
-
Accurate and reproducible diagnosis of peanut allergy using epitope mapping
Suárez-Fariñas, M, Suprun, M, Kearney, P, et al. Allergy. First published: 15 May 2021
-
Development and validation of combined symptom-medication scores for allergic rhinitis
Sousa-Pinto, B., Filipe Azevedo, L., Jutel, M., et al. Allergy. First published: 21 December 2021
-
Overcoming bacteriophage insensitivity in staphylococcus aureus using clindamycin and azithromycinat subinhibitory concentrations
Liu, S., Zhao, Y., Hayes, A., Allergy. 2021; 76: 3446-3458
-
Profound dysregulation of T cell homeostasis and function in patients with severe COVID-19
Adamo, S., Chevrier, S., Cervia, C., et al. Allergy.2021; 76: 2866-2881
-
Prevalence and early-life risk factors of school-age allergic multimorbidity: The EuroPrevall-iFAAM birth cohort
Sigurdardottir, ST, Jonasson, K, Clausen, M, et al. Allergy. 2021; 76: 2855– 2865
-
Gene therapy for a murine model of eosinophilic esophagitis
Camilleri, A.E., Nag, S., Russo, A.R., Stiles, K.M., Crystal, R.G. and Pagovich, O.E. Allergy. 2021; 76: 2740-2752
-
Single-dose prolonged drug provocation test, without previous skin testing, is safe for diagnosing children with mild non-immediate reactions to beta-lactams
Prieto, A., Muñoz, C., Bogas, G., et al. Allergy.2021; 76: 2544-2554
-
Tear N-glycomics in vernal and atopic keratoconjunctivitis
Messina, A., Palmigiano, A., Tosto, C., et al. Allergy.2021; 76: 2500-2509
-
Breastfeeding promotes early neonatal regulatory T-cell expansion and immune tolerance of non-inherited maternal antigens
Wood, H., Acharjee, A., Pearce, H., et al. Allergy.2021; 76: 2447-2460
-
Orofacial granulomatosis: Clinical and therapeutic features in an Italian cohort and review of the literature
Galdiero, M.R., Maio, F., Arcoleo, F., et al. Allergy.2021; 76: 2189-2200
-
Childhood vaccination and allergy: A systematic review and meta-analysis
Navaratna, S., Estcourt, M.J., Burgess, J., et al. Allergy.2021; 76: 2135-2152
-
Elastase and exacerbation of neutrophil innate immunity are involved in multi-visceral manifestations of COVID-19
Guéant, J.-L., Guéant-Rodriguez, R.-M., Fromonot, J., et al. Allergy. 2021; 76: 1846-1858
-
Basophil activation test shows high accuracy in the diagnosis of peanut and tree nut allergy: The markers of nut allergy study
Duan, L, Celik, A, Hoang, JA, et al. Allergy. 2021; 76: 1800– 1812.
-
Digital technology for anaphylaxis management impact on patient behaviour: A randomized clinical trial
Sala-Cunill, A, Luengo, O, Curran, A, et al. Allergy. 2021; 76: 1507– 1516
-
Diagnosing, managing and preventing anaphylaxis: Systematic review
de Silva, D, Singh, C, Muraro, A, et al. Allergy. 2021; 76: 1493– 1506
-
Food-dependent NSAID-induced hypersensitivity (FDNIH) reactions: Unraveling the clinical features and risk factors
Sánchez-López, J, Araujo, G, Cardona, V, et al. Allergy. 2021; 76: 1480– 1492
-
Predicting food allergy: The value of patient history reinforced
Lyons, SA, Knulst, AC, Burney, PGJ, et al. Allergy. 2021; 76: 1454– 1462
-
Predicting persistence of atopic dermatitis in children using clinical attributes and serum proteins
Lauffer, F, Baghin, V, Standl, M, et al. Allergy. 2021; 76: 1158– 1172
-
Accuracy of serological testing for SARS-CoV-2 antibodies: First results of a large mixed-method evaluation study
Brigger, D, Horn, MP, Pennington, LF, et al. Allergy. 2021; 76: 853– 865
-
Diagnostic workup including CD203c-based basophil activation test in immediate hypersensitivity due to metronidazole and ornidazole and evaluation of cross-reactivity in between
Beyaz, Ş, Akdeniz, N, Yılmaz, A, et al. Allergy. 2021; 76: 842– 852
-
Modeling the conversion between specific IgE test platforms for nut allergens in children and adolescents
Hoang, JA, Celik, A, Lupinek, C, et al. et al. Allergy. 2021; 76: 831– 841
-
Antibody dynamics to SARS-CoV-2 in asymptomatic COVID-19 infections
Lei, Q, Li, Y, Hou, H-Y, et al. Allergy. 2021; 76: 551– 561
-
Short-Form Six-Dimensions version 2 preference value set for health utility in food allergy
Dufresne E., Poder, T.G., Samaan, K. et al. Allergy. 2021; 76: 326-228
-
APPEAL-1: A pan-European survey of patient/caregiver perceptions of peanut allergy management
Blumchen, K, DunnGalvin, A, Timmermans, F, et al. Allergy. 2020; 75: 2920– 2935
-
APPEAL-1: A multiple-country European survey assessing the psychosocial impact of peanut allergy
DunnGalvin, A, Blumchen, K, Timmermans, F, et al. Allergy. 2020; 75: 2899– 2908
-
Quality of life of children aged 8-12 years undergoing food allergy oral immunotherapy: Child and parent perspective
Epstein-Rigbi, N, Goldberg, MR, Levy, MB, Nachshon, L, Elizur, A. et al. Allergy. 2020; 75: 2623– 2632
-
IgE to epitopes of Ara h 2 enhance the diagnostic accuracy of Ara h 2-specific IgE
Santos, AF, Barbosa-Morais, NL, Hurlburt, BK, et al. Allergy. 2020; 75: 2309– 2318
-
Orally applied bacterial lysate in infants at risk for atopy does not prevent atopic dermatitis, allergic rhinitis, asthma or allergic sensitization at school age: Follow-up of a randomized trial
Roßberg, S, Keller, T, Icke, K, et al. Allergy. 2020; 75: 2020– 2025
-
Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification
Trizuljak, J, Sperr, WR, Nekvindová, L, et al. Allergy. 2020; 75: 1927– 1938
-
Data-driven step doses for drug provocation tests to nonsteroidal anti-inflammatory drugs
Nohra, D, Molinari, N, Demoly, P, Chiriac, A-M. Allergy. 2020; 75: 1423– 1434
-
Development of the angioedema control test-A patient-reported outcome measure that assesses disease control in patients with recurrent angioedema
Weller, K, Donoso, T, Magerl, M, et al. Allergy. 2020; 75: 1165– 1177
-
The role of drug, dose, and the tolerance/intolerance of new drugs in multiple drug hypersensitivity syndrome
Jörg, L, Yerly, D, Helbling, A, Pichler, W. Allergy. 2020; 75: 1178– 1187
-
ILC3 deficiency and generalized ILC abnormalities in DOCK8-deficient patients
Eken, A, Cansever, M, Okus, FZ, et al. Allergy. 2020; 75: 921– 932
-
Secondary prevention measures in anaphylaxis patients: Data from the anaphylaxis registry
Kraft, M, Knop, MP, Renaudin, J-M, et al. Allergy. 2020; 75: 901– 910
-
Biomarkers and clinical characteristics of autoimmune chronic spontaneous urticaria: Results of the PURIST Study
Schoepke, N, Asero, R, Ellrich, A, et al. Allergy. 2019; 74: 2427– 2436
-
Clinical factors associated with peanut allergy in a high-risk infant cohort
Sicherer, SH, Wood, RA, Perry, TT, et al. Allergy. 2019; 74: 2199– 2211
-
Large local reactions to Hymenoptera stings: Outcome of re-stings in real life
ilò, MB, Martini, M, Pravettoni, V, et al. Allergy. 2019; 74: 1969– 1976
-
Safety and reproducibility of nasal allergen challenge
Eguiluz-Gracia, I, Testera-Montes, A, González, M, et al. Allergy. 2019; 74: 1125– 1134
-
Gene therapy for C1 esterase inhibitor deficiency in a murine model of hereditary angioedema
Qiu, T, Chiuchiolo, MJ, Whaley, AS, et al. Allergy. 2019; 74: 1081– 1089
-
Active vaccination against interleukin-5 as long-term treatment for insect-bite hypersensitivity in horses
Fettelschoss-Gabriel, A, Fettelschoss, V, Olomski, F, et al. Allergy. 2019; 74: 572– 582
-
Quantitative profiling of cytokines and chemokines in DOCK8-deficient and atopic dermatitis patients
Jacob, M, Bin Khalaf, D, Alhissi, S, et al. Allergy. 2019; 74: 370– 379